FAST NEWS: CSPC Pharma’s urticaria drug approved in China
The Latest: CSPC Pharmaceutical Group Ltd. (1093.HK) announced on Tuesday that its chronic spontaneous urticaria treatment, Omalizumab for Injection, has been approved for sale in China by the country’s National Medical Products Administration…
With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs
The Chinese cell therapy specialist, whose core product is still in phase 1 trials, will avoid future cash flow difficulties by selling itself to the European giant Key Takeaways: AstraZeneca…
FAST NEWS: MicroPort MedBot vascular surgical robot approved in China
The latest: Shanghai MicroPort MedBot (Group) Co. Ltd. (2522.HK) announced on Wednesday its R-ONE Vascular Interventional Surgical Robot jointly developed with France’s Robocath S.A.S has been approved by China’s National Medical…
FAST NEWS: InnoCare’s loss narrows on higher lymphoma drug sales
The latest: InnoCare Pharma Ltd. (9969.HK) announced on Monday its third quarter revenue dropped 18.3% year-over-year to 160 million yuan ($21.9 million), while its net loss narrowed 72.2% to 109 million yuan.…
FAST NEWS: Burning Rock’s cancer test gets breakthrough designation
The latest: Cancer screening company Burning Rock Biotech Ltd. (BNR.US) announced Sunday that its OverC multi-cancer detection blood test (MCDBT) has been granted breakthrough device designation by the China National…
Clover Biopharma Gets Critical Cash Booster After Covid Vaccine Approval
The innovative drug maker announced a major share sale a day after its self-developed Covid-19 vaccine got the green light for emergency use in ChinaKey Takeaways:Clover Biopharmaceuticals raised $64 million…
FAST NEWS: CanSino Holds Low Revenue Hopes for Inhaled Covid Booster
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) said Thursday its inhaled recombinant Covid-19 vaccine booster recently began to be administered in 13 cities in Shanghai and Jiangsu province. But it…
Recent Articles
RELATED ARTICLES
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK -
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK
-
Novel drugs lift Sino Biopharm earnings, easing price-cap pain
1177.HK
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
